Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study investigated the association between early-onset vulvar lichen sclerosus in premenopausal women and their use of oral contraceptives.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveFor vulvar Lichen sclerosus (LS) immunological factors, genetic predisposition, and decreased 5 alpha-reductase activity have been discussed as aetiological factors. During the last decade an increase of LS in young women has been suspected. Aim of this study was to evaluate data of premenopausal women with early onset LS to find potential risk factors focussing on the use of oral contraceptives.Study designWe retrospectively analyzed the data of 40 premenopausal patients with early onset LS regarding use of oral contraceptives (OCPs), and first occurrence of LS. To compare these data in a case-control study we analyzed a matched control group of 110 healthy women.ResultsAll our LS patients were using OCPs compared to 73 women (66.4%) in the control group. OCPs with anti-androgenic activity (chlormadinone acetate, cyproterone acetate, dienogest, and drospirenone) were used by 28 (70%) of the LS patients and by 35 (47.9%) of the 73 women using OCPs in the control group. Thus, the odds ratio for early onset LS for women using anti-androgenic OCPs was 2.53 (95% CI: 1.12-5.75).ConclusionOur data suggest that disturbance of the androgen dependent growth of the vulvar skin by OCPs and especially by OCPs with anti-androgenic properties might trigger the early onset of LS in a subgroup of susceptible young women.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Progestogens with Antiandrogenic Properties 2003
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i> 2000
Cited by (1)
References (30)
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i> via openalex
- Progestogens with Antiandrogenic Properties via openalex
- doi:10.1016/j.yexmp.2005.04.007 via openalex
- doi:10.1159/000096736 via openalex
- doi:10.1111/j.1471-0528.1998.tb10056.x via openalex
- doi:10.1016/s1071-5576(98)00033-1 via openalex
- W2236497192 via openalex
- W2400719678 via openalex
- W2416083593 via openalex
- W2418051137 via openalex
- doi:10.1056/nejm198402233100803 via openalex
- W2474144166 via openalex
- W6603735380 via openalex
- W6690057532 via openalex
- W6716776211 via openalex
- W6720555965 via openalex
- doi:10.1016/0002-9378(77)90371-4 via openalex
- doi:10.1177/014107689608901210 via openalex
- doi:10.1016/j.ejcb.2004.12.003 via openalex
- doi:10.1111/j.1365-2559.2005.02209.x via openalex
- doi:10.1016/s0002-9440(10)64924-3 via openalex
- doi:10.1016/s0190-9622(99)70404-4 via openalex
- doi:10.1111/j.1365-2230.1994.tb01183.x via openalex
- doi:10.1016/0002-9378(79)90842-1 via openalex
- doi:10.1111/j.1365-2133.2006.07446.x via openalex
- doi:10.1016/0190-9622(95)90060-8 via openalex
- doi:10.1016/j.jdermsci.2004.10.011 via openalex
- doi:10.1093/aje/kwf180 via openalex
- doi:10.1046/j.1365-2133.2002.05012.x via openalex
- W92933825 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:27:45.971503+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK